Orlen (PKN) Q4 2024 earnings summary

Executive summary

• FY24 revenue was PLN 296.9bn and LIFO EBITDA PLN 35.8bn, down from PLN 372.8bn and PLN 62.6bn; performance reflected weaker markets and comparison with prior-year one-offs.

• FY24 LIFO EBITDA adjusted for regulation, PPA and LNG hedging effects was PLN 43.5bn, versus PLN 39.8bn in FY23.

• Q4 revenue fell to PLN 77.2bn, while net income rose to PLN 4.645bn from PLN 923m, aided by lower impairment charges.

Financial highlights

• FY24 net income was PLN 7.953bn versus PLN 20.969bn; reported EBITDA was PLN 29.6bn versus PLN 45.5bn.

• Q4 LIFO EBITDA was PLN 12.7bn versus PLN 21.1bn; reported EBITDA was PLN 11.5bn versus PLN 6.6bn.

• FY24 operating cash flow was PLN 36.6bn versus PLN 41.9bn; free cash flow was PLN 2.6bn versus PLN 5.5bn.

• Net debt/EBITDA was 0.30x at FY24 versus 0.02x at FY23; net financial debt was PLN 7.0bn, up PLN 5.2bn year on year.

Outlook and guidance

• 2025 planned CAPEX is PLN 32.4bn, including PLN 24.4bn for development and PLN 8.0bn for maintenance, excluding M&A and offshore investment.

• 2025 earnings tailwinds include no negative regulatory charges, higher gas prices, potentially higher US gas imports, improved white-product yields and higher retail fuel volumes; headwinds include lower oil output, narrower gas spreads and weaker refining and petrochemicals.

• Planned developments include Yggdrasil, Tommeliten Alpha and Fenris, Baltic offshore wind, Ostrołęka and Grudziądz CCGTs, and Nowa Chemia.

• Redesigned Nowa Chemia targets 740kt annual ethylene capacity, commissioning no earlier than 2030 and investment of ~PLN 34bn; incremental 2030 EBITDA is estimated at PLN 550–800m annually.